Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan H Fox

Showing results (1-10 of 178) with videos related to

Pageof 18
Sort By:
Drugs|August 7, 2013
Non-dopaminergic treatments for motor control in Parkinson's diseaseSusan H Fox
Continuum (Minneapolis, Minn.)|August 7, 2016
Patient Management ProblemSusan H Fox
Lancet (London, England)|November 5, 2013
Pimavanserin as treatment for Parkinson's disease psychosisSusan H Fox
Movement Disorders Clinical Practice|June 3, 2024
Outcome Selection for Research Studies in Movement DisordersSusan H Fox
Movement Disorders : Official Journal of the Movement Disorder Society|August 23, 2012
Improved viability of stem cell transplants in animal models of Parkinson's diseaseSusan H Fox
Continuum (Minneapolis, Minn.)|August 7, 2016
Patient Management Problem-Preferred ResponsesSusan H Fox
Movement Disorders : Official Journal of the Movement Disorder Society|May 17, 2013
Metabolic disorders causing movement disorders in childhood; an addition to the listSusan H Fox
The Lancet. Neurology|November 19, 2022
Revisiting levodopa for advanced Parkinson's diseaseSusan H Fox
Drugs|August 10, 2016
Erratum to: Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and ManagementAnna Chang, Susan H Fox
Movement Disorders : Official Journal of the Movement Disorder Society|March 13, 2015
Orthostatic hypotension in Parkinsonism: What is it and how can we treat it?Susan H Fox, Connie Marras
Pageof 18

Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
Drugs|August 7, 2013
Non-dopaminergic treatments for motor control in Parkinson's diseaseSusan H Fox
Continuum (Minneapolis, Minn.)|August 7, 2016
Patient Management ProblemSusan H Fox
Lancet (London, England)|November 5, 2013
Pimavanserin as treatment for Parkinson's disease psychosisSusan H Fox
Movement Disorders Clinical Practice|June 3, 2024
Outcome Selection for Research Studies in Movement DisordersSusan H Fox
Movement Disorders : Official Journal of the Movement Disorder Society|August 23, 2012
Improved viability of stem cell transplants in animal models of Parkinson's diseaseSusan H Fox
Continuum (Minneapolis, Minn.)|August 7, 2016
Patient Management Problem-Preferred ResponsesSusan H Fox
Movement Disorders : Official Journal of the Movement Disorder Society|May 17, 2013
Metabolic disorders causing movement disorders in childhood; an addition to the listSusan H Fox
The Lancet. Neurology|November 19, 2022
Revisiting levodopa for advanced Parkinson's diseaseSusan H Fox
Drugs|August 10, 2016
Erratum to: Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and ManagementAnna Chang, Susan H Fox
Movement Disorders : Official Journal of the Movement Disorder Society|March 13, 2015
Orthostatic hypotension in Parkinsonism: What is it and how can we treat it?Susan H Fox, Connie Marras
Pageof 18